This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Power Device Company Maplesemi Completes Series A+ Financing Round
Acoustic Technology Company Audfly Completes Series B Financing Round
Wicue Raised CNY 200 Mn in Series C+ Financing Round
New Import Tax Regulations in Brazil: Cross-Border Shopping to Enjoy Tax Discounts
EqualOcean reports that starting August 1, 2024, under Brazil's newly passed Law No. 914/2024, purchases over USD 50 on international cross-border shopping platforms that are part of the "Conforme Remessa" import tax compliance program will benefit from reduced import taxes.
Jul 09, 2024 07:13 PM
Jinyu medicine: we are actively cooperating in the investigation of Jinyu incident in Zhengzhou
Chile's GDP Growth Forecast at 2.2% Over Next Decade, Below Major Latin American Economies
Recently, 28 international and domestic financial institutions released the Consensus Forecasts report, predicting that Chile's gross domestic product (GDP) will grow at an average rate of 2.2% over the next decade. This forecast places Chile behind major Latin American economies such as Peru (2.9%), Colombia (2.8%), Argentina (2.4%), and Mexico (2.4%), and just above Brazil (2%).
Jun 26, 2024 06:33 PM
Gilid signed an agreement with science and technology to deepen strategic cooperation in the areas of chronic hepatitis B, hepatitis C and HIV infection.
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%